Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any autosomal dominant polycystic liver disease in which the cause of the disease is a mutation in the SEC61B gene.
Biomarker and diagnostic research for SEC61B-related polycystic liver disease has been reported in the published literature.
No clinical trials have been registered for SEC61B-related polycystic liver disease.
103 publications have been identified in PubMed for SEC61B-related polycystic liver disease. Research spans Case Report / Case Series (30%), Review / Meta-Analysis (26%), and Clinical Trial Publication (11%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 31 | 30% |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 1:02 AM UTC
Common questions about SEC61B-related polycystic liver disease
Research summaries
27 |
26% |
Clinical study results | 11 | 11% |
Laboratory research | 11 | 11% |
Disease patterns and progression | 8 | 8% |
Testing and diagnosis research | 7 | 7% |
New treatment approaches | 7 | 7% |
Other research | 1 | 1% |
Brambilla Pisoni M (2026). [PMID: 41751804](https://pubmed.ncbi.nlm.nih.gov/41751804/). *International journal of molecular sciences*. [Review / Meta-Analysis]
Heinrich S (2026). [PMID: 41328663](https://pubmed.ncbi.nlm.nih.gov/41328663/). *Liver international : official journal of the International Association for the Study of the Liver*. [Review / Meta-Analysis]
Furlano M (2026). [PMID: 41788616](https://pubmed.ncbi.nlm.nih.gov/41788616/). *Clinical kidney journal*. [Review / Meta-Analysis]
Inamura Y (2026). [PMID: 41553611](https://pubmed.ncbi.nlm.nih.gov/41553611/). *CEN case reports*. [Review / Meta-Analysis]
Rezaei E (2026). [PMID: 41808648](https://pubmed.ncbi.nlm.nih.gov/41808648/). *Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation*. [Case Report / Case Series]
Ortega-Macías AG (2026). [PMID: 41994676](https://pubmed.ncbi.nlm.nih.gov/41994676/). *Cureus*. [Case Report / Case Series]
Abraham A (2026). [PMID: 42087729](https://pubmed.ncbi.nlm.nih.gov/42087729/). *Int J Surg Pathol*. [Review / Meta-Analysis]
Lai B (2026). [PMID: 42070937](https://pubmed.ncbi.nlm.nih.gov/42070937/). *Dig Liver Dis*. [Other]
Asanuma S (2026). [PMID: 42043748](https://pubmed.ncbi.nlm.nih.gov/42043748/). *Clin J Gastroenterol*. [Case Report / Case Series]
Hejazee MF (2026). [PMID: 41590402](https://pubmed.ncbi.nlm.nih.gov/41590402/). *Khirurgiia (Mosk)*. [Case Report / Case Series]